| 02/06/25 | 15:15:00 | 2 Jun 2025 | | Block Listing Six Monthly Return |
| 27/05/25 | 07:00:15 | 27 May 2025 | | Notice of AGM and availability of Annual Report |
| 24/04/25 | 07:00:13 | 24 Apr 2025 | | Change of Broker |
| 15/04/25 | 07:00:05 | 15 Apr 2025 | | Results for the Year ended 31 December 2024 |
| 10/04/25 | 13:30:00 | 10 Apr 2025 | | Notice of Results and Investor Presentation |
| 31/03/25 | 07:00:15 | 31 Mar 2025 | | Board Appointment |
| 30/01/25 | 07:00:07 | 30 Jan 2025 | | FY24 Trading Update and FY25 Outlook |
| 15/01/25 | 07:00:05 | 15 Jan 2025 | | Positive results from WSD4000 Home User study |
| 13/01/25 | 07:00:06 | 13 Jan 2025 | | Remuneration of Non-Executive Directors and TVR's |
| 20/12/24 | 07:58:11 | 20 Dec 2024 | | Holding(s) in Company |
| 02/12/24 | 07:00:07 | 2 Dec 2024 | | Block Listing Six Monthly Return |
| 15/11/24 | 07:00:06 | 15 Nov 2024 | | TR-1: Notification of major holdings |
| 04/11/24 | 07:00:07 | 4 Nov 2024 | | Encouraging New Product Development Pipeline |
| 31/10/24 | 07:00:03 | 31 Oct 2024 | | Total Voting Rights |
| 17/10/24 | 14:00:00 | 17 Oct 2024 | | Clinical trial data presented at SMSNA |
| 07/10/24 | 07:00:03 | 7 Oct 2024 | | Further milestone payment triggered post US launch |
| 01/10/24 | 07:00:04 | 1 Oct 2024 | | Total Voting Rights |
| 13/09/24 | 07:00:08 | 13 Sept 2024 | | Directors’ / PDMR Dealing |
| 11/09/24 | 17:43:40 | 11 Sept 2024 | | Trinity Delta research note & consensus forecasts |
| 10/09/24 | 07:00:05 | 10 Sept 2024 | | Futura Medical - Interim Results 2024 |
| 02/09/24 | 10:47:07 | 2 Sept 2024 | | Update on US Launch |
| 02/09/24 | 07:00:04 | 2 Sept 2024 | | Update on US launch |
| 19/08/24 | 07:00:14 | 19 Aug 2024 | | Notice of Results |
| 01/08/24 | 07:05:00 | 1 Aug 2024 | | Update on US launch |
| 01/07/24 | 14:13:26 | 1 Jul 2024 | | Total Voting Rights |
| 01/07/24 | 07:00:07 | 1 Jul 2024 | | Nominated Adviser and Joint Broker |
| 20/06/24 | 16:12:30 | 20 Jun 2024 | | Result of AGM |
| 20/06/24 | 07:00:05 | 20 Jun 2024 | | AGM Statement |
| 31/05/24 | 07:00:11 | 31 May 2024 | | Block Listing Six Monthly Review |
| 24/05/24 | 07:00:05 | 24 May 2024 | | Notice of AGM and availability of Annual Report |
| 29/04/24 | 07:00:12 | 29 Apr 2024 | | Directors’ / PDMR Dealing and Grant of Options |
| 10/04/24 | 07:00:07 | 10 Apr 2024 | | Results for the Year ended 31 December 2023 |
| 25/03/24 | 07:00:08 | 25 Mar 2024 | | Notice of Results and Investor Presentation |
| 14/02/24 | 07:00:06 | 14 Feb 2024 | | Eroxon to be available on prescription |
| 06/02/24 | 07:01:00 | 6 Feb 2024 | | Trading Update |
| 06/02/24 | 07:00:08 | 6 Feb 2024 | | Appointment of Joint Corporate Broker |
| 17/01/24 | 07:00:06 | 17 Jan 2024 | | Director/PDMR Dealing |
| 17/01/24 | 07:00:02 | 17 Jan 2024 | | Remuneration of Non-Exec Directors & Voting Rights |
| 15/01/24 | 07:00:02 | 15 Jan 2024 | | Futura Medical extends collaboration with Cooper |
| 09/01/24 | 07:00:04 | 9 Jan 2024 | | Appointment of Roy Davis as Non-Executive Director |
| 30/11/23 | 15:10:56 | 30 Nov 2023 | | Total Voting Rights |
| 30/11/23 | 15:10:49 | 30 Nov 2023 | | Block Listing Six Monthly Return |
| 07/11/23 | 07:00:08 | 7 Nov 2023 | | Futura expands partnership with M8 Pharmaceuticals |
| 02/11/23 | 15:34:51 | 2 Nov 2023 | | Eroxon Awarded “New Product of the Year” by Boots |
| 31/10/23 | 07:00:06 | 31 Oct 2023 | | Block Listing Application and Total Voting Rights |
| 25/10/23 | 07:00:14 | 25 Oct 2023 | | Eroxon® Granted Marketing Authorisation in Mexico |
| 19/10/23 | 07:00:13 | 19 Oct 2023 | | Eroxon Launches in the United Arab Emirates |
| 10/10/23 | 07:00:11 | 10 Oct 2023 | | Directors’/PDMR Dealing and Grant of Options |
| 02/10/23 | 07:00:04 | 2 Oct 2023 | | European Patent Granted for MED3000 until 2040 |
| 18/09/23 | 07:00:02 | 18 Sept 2023 | | Futura Medical - Interim Results 2023 |
